====== NFN1 1μM R03 exp100 ======
==== Mechanism of Action ====
Nitrofuran derivative, candidate ALDH2 inhibitor
* **Class / Subclass 1:** Infectious Disease / Antibiotic
==== Technical Notes ====
* **PubChem Name:** %%Ethyl 5-ethyl-2-[(5-nitrofuran-2-carbonyl)amino]thiophene-3-carboxylate%%
* **Synonyms:** N/A
* **CAS #:** 219620-36-7
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/2799305|2799305]]
* **IUPAC:** %%ethyl 5-ethyl-2-[(5-nitrofuran-2-carbonyl)amino]thiophene-3-carboxylate%%
* **INCHI Name:** InChI=1S/C14H14N2O6S/c1-3-8-7-9(14(18)21-4-2)13(23-8)15-12(17)10-5-6-11(22-10)16(19)20/h5-7H,3-4H2,1-2H3,(H,15,17)
* **INCHI Key:** OASNGLRREXBINI-UHFFFAOYSA-N
* **Molecular Weight:** 338.34
* **Canonical SMILES:** CCC1=CC(=C(S1)NC(=O)C2=CC=C(O2)[N+](=O)[O-])C(=O)OCC
* **Isomeric SMILES:** N/A
* **Molecular Formula:** C14H14N2O6S
{{:chemogenomics:structures:chem-0029.svg?nolink}}
* **Supplier Name:** Maybridge
* **Catalog #:** BTB05727SC
* **Lot #:** N/A
* **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C14H14N2O6S 339.06453; found 339.0634
* **Platform ID:** NFN1
* **Min:** -1.7682; **Max:** 66.1639
{{:chemogenomics:dose_response:dr_100.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |0.3734 |
| IC30 |1.2393 |
| IC40 |3.3135 |
| IC50 |8.1701 |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 03
* **Dose**: 1µM
* **Days of incubation**: 8
* **Doublings**: 6.9
* **Numbers of reads**: 10917491
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|1/0|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/NFN1_1uM_Round-3_exp100.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp100.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:G:GTPBP2|GTPBP2]]|-3.08|<0.01|
|[[:human_genes:P:PUS7|PUS7]]|-2.76|0.12|
|[[:human_genes:P:PRAMEF25|PRAMEF25]]|-2.72|0.60|
|[[:human_genes:P:PRAMEF26|PRAMEF26]]|-2.70|0.61|
|[[:human_genes:T:TCF4|TCF4]]|-2.45|0.23|
|[[:human_genes:C:CCNC|CCNC]]|-2.40|0.23|
|[[:human_genes:K:KDSR|KDSR]]|-2.33|0.23|
|[[:human_genes:M:MCM9|MCM9]]|-2.32|0.23|
|[[:human_genes:S:SLC12A2|SLC12A2]]|-2.30|0.23|
|[[:human_genes:D:DNAJB11|DNAJB11]]|-2.29|0.23|
|[[:human_genes:M:MNS1|MNS1]]|-2.28|0.51|
|[[:human_genes:A:ASNSD1|ASNSD1]]|-2.28|0.23|
|[[:human_genes:F:FLCN|FLCN]]|-2.25|0.23|
|[[:human_genes:X:XPOT|XPOT]]|-2.24|0.23|
|[[:human_genes:E:ERCC5|ERCC5]]|-2.23|0.23|
|[[:human_genes:R:RTEL1|RTEL1]]|-2.18|0.23|
|[[:human_genes:M:MAD2L2|MAD2L2]]|-2.14|0.23|
|[[:human_genes:T:TRAPPC13|TRAPPC13]]|-2.12|0.23|
|[[:human_genes:A:ACIN1|ACIN1]]|-2.10|0.37|
|[[:human_genes:C:C1orf109|C1orf109]]|-2.09|0.37|
|[[:human_genes:T:TSR3|TSR3]]|-2.07|0.29|
|[[:human_genes:L:LMAN1L|LMAN1L]]|-2.05|0.39|
|[[:human_genes:D:DPAGT1|DPAGT1]]|-2.04|0.59|
|[[:human_genes:P:PRR21|PRR21]]|-2.01|0.37|
|[[:human_genes:P:PUS3|PUS3]]|-2.00|0.37|
|[[:human_genes:T:TMA16|TMA16]]|-1.99|0.47|
|[[:human_genes:G:GPR107|GPR107]]|-1.99|0.37|
|[[:human_genes:G:GCK|GCK]]|-1.98|0.51|
|[[:human_genes:S:SCAI|SCAI]]|-1.98|0.37|
|[[:human_genes:T:TNIP1|TNIP1]]|-1.94|0.39|
|[[:human_genes:G:GAR1|GAR1]]|1.87|0.67|
|[[:human_genes:A:ATAD2B|ATAD2B]]|1.89|0.67|
|[[:human_genes:A:AGL|AGL]]|1.89|0.67|
|[[:human_genes:N:NDC80|NDC80]]|1.90|0.76|
|[[:human_genes:R:RAPSN|RAPSN]]|1.90|0.67|
|[[:human_genes:K:KRTAP10-9|KRTAP10-9]]|1.91|0.67|
|[[:human_genes:B:BTK|BTK]]|1.92|0.67|
|[[:human_genes:O:OR5T2|OR5T2]]|1.94|0.67|
|[[:human_genes:C:CCDC38|CCDC38]]|1.94|0.67|
|[[:human_genes:A:ARF4|ARF4]]|1.96|0.67|
|[[:human_genes:R:RPL8|RPL8]]|1.96|0.68|
|[[:human_genes:C:CARF|CARF]]|1.98|0.67|
|[[:human_genes:P:PRKCB|PRKCB]]|1.98|0.67|
|[[:human_genes:I:ITPR1|ITPR1]]|2.00|0.67|
|[[:human_genes:G:GART|GART]]|2.06|0.67|
|[[:human_genes:C:CNOT2|CNOT2]]|2.06|0.67|
|[[:human_genes:Z:ZXDB|ZXDB]]|2.06|0.67|
|[[:human_genes:N:NCF4|NCF4]]|2.07|0.67|
|[[:human_genes:T:TOP1MT|TOP1MT]]|2.12|0.67|
|[[:human_genes:R:RNF4|RNF4]]|2.12|0.67|
|[[:human_genes:C:CCDC71L|CCDC71L]]|2.15|0.67|
|[[:human_genes:N:NHP2L1|NHP2L1]]|2.16|0.67|
|[[:human_genes:C:CIB4|CIB4]]|2.17|0.67|
|[[:human_genes:K:KPNB1|KPNB1]]|2.18|0.76|
|[[:human_genes:N:NUS1|NUS1]]|2.20|0.67|
|[[:human_genes:S:STK38|STK38]]|2.23|0.67|
|[[:human_genes:H:HNRNPM|HNRNPM]]|2.26|0.67|
|[[:human_genes:H:HSPA5|HSPA5]]|2.29|0.67|
|[[:human_genes:Z:ZNF845|ZNF845]]|2.57|0.66|
|[[:human_genes:C:COPB2|COPB2]]|2.65|0.67|
^Screen^Correlation^Plot^
|[[:results:exp389|PF-06409577 20μM R07 exp389]]|0.069||
|[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|0.051||
|[[:results:exp99|NFN1 0.4μM R03 exp99]]|0.052||
{{:chemogenomics:comparison_plots:exp100_vs_exp389.png?nolink |}}
{{:chemogenomics:comparison_plots:exp100_vs_exp249.png?nolink |}}
{{:chemogenomics:comparison_plots:exp100_vs_exp99.png?nolink |}}
^GO Term^Fold Change^Genes^
|pseudouridine synthesis|112.53|PUS7,TSR3,PUS3|
No GO term hits below threshold. (FDR <0.05)